4European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens, 2003,21:1011-1053.
5Chobanian AV, Bakris GL, Black HR ,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA, 2003,289 : 2560 -2572.
7Meredith PA. How to evaluate the duration of blood pressure control :the trough: peak ratio and 24-hour monitoring. J Cardiovasc Pharmacol,1998,31 (Suppl 2) :S17-21.
8Rizzoni D, Parati G, Omboni S, et al. Smoothness index but not T/P ratio estimates balanced 24 - hour blood pressure control and predicts regression of organ damage by antihypertensive treatment. J Hypertens, 1997,15 :S7-11.
9Lopez-Sendon J,Swedberg K,McMurray J,et al.Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease.The Task Force on ACE-inhibitors of the European Society of Cardiology.Eur Heart J,2004,25(16):1454-1470.
10The Heart Outcomes Prevention Evaluation Study Investigators.Effects of an angiotensin-converting-enzyme inhibitor,ramipril,on cardiovascular events in high-risk patients.N Engl J Med,2000,342 (3):145-153.
